BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 12199724)

  • 1. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD; Wong IC; Polizzi G; Sander JW
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine.
    Rowan AJ; Ramsay RE; Collins JF; Pryor F; Boardman KD; Uthman BM; Spitz M; Frederick T; Towne A; Carter GS; Marks W; Felicetta J; Tomyanovich ML;
    Neurology; 2005 Jun; 64(11):1868-73. PubMed ID: 15955935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotherapy trials with gabapentin for partial epilepsy.
    Beydoun A
    Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
    McLean MJ; Morrell MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus-Miller L; Bernstein P; Rose-Legatt A
    Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin.
    Morris GL
    Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
    Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
    Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy.
    Wong IC; Chadwick DW; Fenwick PB; Mawer GE; Sander JW
    Epilepsia; 1999 Oct; 40(10):1439-45. PubMed ID: 10528941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
    Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
    Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.
    Frye MA; Ketter TA; Kimbrell TA; Dunn RT; Speer AM; Osuch EA; Luckenbaugh DA; Cora-Ocatelli G; Leverich GS; Post RM
    J Clin Psychopharmacol; 2000 Dec; 20(6):607-14. PubMed ID: 11106131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine.
    Sethi A; Chandra D; Puri V; Mallika V
    Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.
    Steiner TJ; Dellaportas CI; Findley LJ; Gross M; Gibberd FB; Perkin GD; Park DM; Abbott R
    Epilepsia; 1999 May; 40(5):601-7. PubMed ID: 10386529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new antiepileptic drugs: a systematic review of their efficacy and tolerability.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Epilepsia; 1997 Aug; 38(8):859-80. PubMed ID: 9579887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE
    Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom.
    Wong IC; Mawer GE; Sander JW
    Epilepsia; 2001 Feb; 42(2):237-44. PubMed ID: 11240596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
    Leach JP; Girvan J; Paul A; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients.
    Wilson EA; Sills GJ; Forrest G; Brodie MJ
    Epilepsy Res; 1998 Jan; 29(2):161-6. PubMed ID: 9477149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
    Handforth A; Treiman DM
    Epilepsia; 1994; 35(5):1032-7. PubMed ID: 7925148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.